The White House’s weight-loss drug briefing was halted after Novo Nordisk executive Gordon Findlay fainted on camera, ...

Oz acknowledged obesity isn't "a deficiency of GLP drugs" but called reducing costs "a belt-and-suspenders approach." ...

As demand for Ozempic, Wegovy and Zepbound grows, local patients say cost remains the biggest barrier ...

The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

President Donald Trump promises lower prices for weight loss drugs and reveals, one of his key staff members has a ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Even after Trump’s new deal, obesity drugs are still too expensive.

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

RFK Jr. has railed against drugmakers but he struck a different tone in commenting on President Trump's deal to expand access to obesity drugs ...